Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention
Pharmaceuticals · 2026-08-19 · 19 (8) · 1308
DOI: 10.3390/ph19081308 ↗At a glance
Editorial in Pharmaceuticals, published online on 2026-08-19. Written by Engi Algharably and 1 co-authors. Institution: Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacolo…. 5 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Optimizing pharmacotherapy is a central goal of clinical pharmacology [...]
Authors and institutions
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Charitéplatz 1, 10117 Berlin, Germany.
ORCID profiles: Engi Algharably
Cite
APA
Algharably, E., & Gundert-Remy, U. (2026). Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention. Pharmaceuticals, 19(8), 1308. https://doi.org/10.3390/ph19081308
Vancouver
Algharably E, Gundert-Remy U. Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention. Pharmaceuticals. 2026;19(8):1308. doi:10.3390/ph19081308
BibTeX
@article{Algharably2026,
author = {Algharably, Engi and Gundert-Remy, Ursula},
title = {Therapeutic Drug Monitoring and Adverse Drug Reactions: From Signal Detection to Prevention},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {8},
pages = {1308},
doi = {10.3390/ph19081308}
}
EUVIMED